| Hans-Günter Meyer-Thompson | Opioide
Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol.
Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol.
Peacock A, Larance B, Farrell M, Cairns R, Buckley N, Degenhardt L.
BMJ Open. 2018 Mar 23;8(3):e020006. doi: 10.1136/bmjopen-2017-020006.